DOES SWITCHING BETWEEN 5-AMINOSALICYLATES AFFECT THIOPURINE METABOLISM AND CLINICAL OUTCOMES IN PATIENT WITH ULCERATIVE COLITIS?

被引：0
|
作者：
Morikubo, Hiromu
Ozaki, Ryo
Okabayashi, Shinji
Kiyohara, Hiroki
Matsubayashi, Mao
Sagami, Shintaro
Nakano, Masaru
Ikezaki, Osamu
Hisamatsu, Tadakazu
Hibi, Toshifumi
Kobayashi, Taku
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1838
引用
收藏
页码：S1144 / S1144
页数：1
相关论文
共 50 条
  • [31] Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice
    Ben-Horin, Shomron
    Andrews, Jane M.
    Katsanos, Konstantinos H.
    Rieder, Florian
    Steinwurz, Flavio
    Karmiris, Konstantinos
    Cheon, Jae Hee
    Moran, Gordon William
    Cesarini, Monica
    Stone, Christian D.
    Schwartz, Doron
    Protic, Marijana
    Roblin, Xavier
    Roda, Giulia
    Chen, Min-Hu
    Har-Noy, Ofir
    Bernstein, Charles N.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (16) : 2995 - 3002
  • [32] IMPACT OF CONTINUING 5-AMINOSALICYLATES IN PATIENTS WITH ULCERATIVE COLITIS ESCALATED TO BIOLOGIC THERAPY: POOLED ANALYSIS OF INDIVIDUAL PARTICIPANT DATA FROM INFLIXIMAB AND GOLIMUMAB CLINICAL TRIALS
    Singh, Siddharth
    Proudfoot, James
    Fumery, Mathurin
    Dulai, Parambir
    Boland, Brigid S.
    Xu, Ronghui
    Sandborn, William J.
    GASTROENTEROLOGY, 2018, 154 (06) : S111 - S111
  • [33] Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis
    Ford, Alexander C.
    Khan, Khurram J.
    Achkar, Jean-Paul
    Moayyedi, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (02): : 167 - 176
  • [34] Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice
    Shomron Ben-Horin
    Jane M Andrews
    Konstantinos H Katsanos
    Florian Rieder
    Flavio Steinwurz
    Konstantinos Karmiris
    Jae Hee Cheon
    Gordon William Moran
    Monica Cesarini
    Christian D Stone
    Doron Schwartz
    Marijana Protic
    Xavier Roblin
    Giulia Roda
    Min-Hu Chen
    Ofir Har-Noy
    Charles N Bernstein
    World Journal of Gastroenterology, 2017, (16) : 2995 - 3002
  • [35] Does patient knowledge affect the colorectal cancer risk in ulcerative colitis?
    Eaden, JA
    Abrams, K
    Mayberry, JF
    POSTGRADUATE MEDICAL JOURNAL, 2002, 78 (924) : 615 - 618
  • [36] Gap between evidence and clinical practice: 5-aminosalicylates are frequently used for Crohn's Disease treatment
    Schoepfer, Alain
    Bortolotti, Murielle
    Pittet, Valerie
    Mottet, Christian
    Gonvers, Jean-Jacques
    Reich, Oliver
    Fournier, Nicolas
    Vader, John-Paul
    Burnand, Bernard
    Michetti, Pierre
    Froehlich, Florian
    SWISS MEDICAL WEEKLY, 2014, 144 : 10S - 10S
  • [37] Tofacitinib efficacy in patients with moderate to severe ulcerative colitis: Subgroup analyses of OCTAVE Induction 1 and 2 and OCTAVE Sustain by 5-aminosalicylates use
    Hanauer, S.
    Rubin, D. T.
    Gionchetti, P.
    Su, C.
    Woodworth, D. A.
    Quirk, D.
    Salese, L.
    Wang, W.
    Marren, A.
    Lawendy, N.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S477 - S477
  • [38] Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX versus 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and meta-analysis
    Barberio, Brigida
    Marsilio, Ilaria
    Buda, Andrea
    Bertin, Luisa
    Semprucci, Gianluca
    Zanini, Annalisa
    Crepaldi, Martina
    Zingone, Fabiana
    Savarino, Edoardo
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [39] EXAGGERATED ACUTE INFLAMMATION IN ULCERATIVE COLITIS, AND PROMOTION OF ITS RESOLUTION BY 5-AMINOSALICYLATES THROUGH ANTI-INFLAMMATORY HYDROXY FATTY ACID BIOSYNTHESIS
    Marks, D. J.
    Wysoczanski, R.
    Kendall, A. C.
    Motwani, M.
    Vega, R.
    Rahman, F. Z.
    McCartney, S.
    Bloom, S. L.
    Nicolaou, A.
    Gilroy, D. W.
    Segal, A. W.
    GUT, 2017, 66 : A25 - A26
  • [40] Tofacitinib Efficacy in Patients With Moderate to Severe Ulcerative Colitis: Subgroup Analyses of OCTAVE Induction 1 & 2 and OCTAVE Sustain by 5-Aminosalicylates Use
    Hanauer, Stephen B.
    Rubin, David T.
    Gionchetti, Paolo
    Su, Chinyu
    Woodworth, Deborah A.
    Quirk, Daniel
    Salese, Leonardo
    Wang, Wenjin
    Marren, Amy
    Lawendy, Nervin
    Panaccione, Remo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S483 - S484
12345